相关实验视频

Updated: Jun 14, 2025

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

基于甘氨酸的治疗方法治疗膀癌:克服临床障碍

Rui Freitas¹, Andreia Peixoto², Lúcio Lara Santos³

¹Experimental Pathology and Therapeutics Group, Research Center of IPO-Porto (CI-IPOP), 4200-072 Porto, Portugal; CI-IPOP@RISE (Health Research Network), Portuguese Oncology Institute of Porto (IPO-Porto)/Porto Comprehensive Cancer Center Raquel Seruca (Porto.CCC Raquel Seruca), 4200-072 Porto, Portugal; ICBAS - School of Medicine and Biomedical Sciences, University of Porto, 4050-313 Porto, Portugal; i3S - Institute for Research and Innovation in Health (i3S), University of Porto, 4200-135 Porto, Portugal.

Biochimica et biophysica acta. Reviews on cancer

|April 24, 2025

概括

膀癌 (BLCA) 由于异质性而带来治疗挑战. 异常的糖基化提供了一个独特的机会,用于开发新的,针对BLCA的基于甘氨酸的治疗方法.

科学领域:

在瘤学瘤学.
生物化学生物化学

背景情况:

膀癌 (BLCA) 是一个主要的全球健康问题,发病率,复发率和死亡率很高.
疾病的异质性和快速进展使管理和生物标志物发现复杂化.
目前的疗法往往不够,需要个性化治疗策略.

研究的目的:

为BLCA管理中的临床挑战提供全面的概述.
审查BLCA新兴的新疗法.
突出癌症相关异常糖基化作为新型BLCA疗法的标的潜力.

主要方法:

本综述综合了关于BLCA管理和治疗的当前文献.
它探讨了抗瘤免疫疗法的作用及其局限性.
它专注于糖基化变化作为潜在的治疗途径.

主要成果:

在BLCA中免疫疗法的有效性受到低瘤突变负担的限制,阻碍了新抗原呈现.
与癌症相关的异常糖化呈现出独特的BLCA特异性特征.
糖基化变化为有针对性的治疗开发提供了一个有希望的途径.

结论:

新的,个性化的方法对于有效的BLCA管理至关重要.
异常的糖化化为开发基于甘氨酸的创新疗法提供了独特的机会.
准糖基化变化可能会彻底改变膀癌治疗策略.

关键词:

异常的糖化化.膀癌是一种癌症.葡萄糖蛋白质组 (Glycoproteome) 是一种葡萄糖蛋白质组.有针对性的治疗方法.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Culture of Bladder Cancer Organoids as Precision Medicine Tools

Published on: December 28, 2021

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...